The expanding popularity in peptides has given rise to a large grey industry, presenting serious risks to individuals. Such materials are frequently manufactured beyond controlled governmental oversight, implying the quality and strength can be extremely inconsistent. Moreover, these sources may lack correct data regarding ingredients, potential un